YANTAI, China, June 3, 2024 /PRNewswire/ — RemeGen Co., Ltd. (“RemeGen” or “the Company”) (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center Phase I/II study evaluating RC88 in patients with…

NEW YORK, June 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Malibu Boats, Inc. (NASDAQ: MBUU) between November 4, 2022 and April 11, 2024, both dates inclusive (the “Class Period”), of the important June 28, 2024 lead…

NEW YORK, June 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Malibu Boats, Inc. (NASDAQ: MBUU) between November 4, 2022 and April 11, 2024, both dates inclusive (the “Class Period”), of the important June 28, 2024 lead…

NEW YORK, June 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2024 lead plaintiff…

NEW YORK, June 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2024 lead plaintiff…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.